Ontario’s Avivagen Sells Pet Chews in China

Ottawa-headquartered Avivagen Inc., which operates in the multi-billion-dollar animal and human health markets, has made its first sale of Vivamune Health Chews into the Chinese market through an arrangement with China's Pawllion Inc. China is the third-largest pet market in the world with a growth rate of over 20 per cent for 2017. Vivamune Health Chews are a supplement for companion animals. The distribution agreement will include both mainland China and Hong Kong, and Pawllion will be featuring Vivamune Health Chews at Pet Fair Asia, the largest pet exhibition in Asia, from Aug. 22 to Aug. 26, 2018.

Use 'AND' or 'OR' to refine your search.

Use quotes " " to get exact matches or remove them to get more results.